Alto Ingredients (ALTO) Cash & Equivalents (2010 - 2026)

Alto Ingredients' Cash & Equivalents history runs 17 years deep, the most recent figure standing at $20.3 million for Q1 2026.

• On a quarterly basis, Cash & Equivalents fell 24.16% year-over-year to $20.3 million in Q1 2026; TTM through Mar 2026 was $20.3 million, a 24.16% decrease from a year earlier, with the FY2025 full-year figure at $23.4 million, down 33.98% from the prior year.
• Cash & Equivalents fell to $20.3 million in Q1 2026 per ALTO's latest filing, from $23.4 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $57.4 million in Q2 2022 and bottomed at $20.3 million in Q1 2026.
• The 5-year median for Cash & Equivalents is $29.3 million (2024), against an average of $30.4 million.
• Across the five-year window, Cash & Equivalents sank 60.37% in 2023 and jumped 38.43% in 2024, its largest moves.
• Year by year, Cash & Equivalents stood at $36.5 million in 2022, then fell by 17.67% to $30.0 million in 2023, then rose by 18.17% to $35.5 million in 2024, then sank by 33.98% to $23.4 million in 2025, then retreated by 13.27% to $20.3 million in 2026.
• Per Business Quant, the three latest ALTO Cash & Equivalents figures stand at $20.3 million (Q1 2026), $23.4 million (Q4 2025), and $32.5 million (Q3 2025).